Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 12/20 | 0.40 |
| ▸ | PTGIR | P43119 | 12/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | FHIT | P49789 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6276234 | 0.86 | ALDH1A1 (0.41) | KDM4EALDH1A1HPGDTDP1TBXA2R | |
| SCHEMBL6276229 | 0.86 | ALDH1A1 (0.41) | KDM4EALDH1A1HPGDTDP1TBXA2R | |
| SCHEMBL6275414 | 0.85 | IDO1 (0.36) | ADORA3ADORA2AADORA1 | |
| SCHEMBL6276928 | 0.84 | ALDH1A1 (0.40) | KDM4EALDH1A1HPGDTDP1TBXA2R | |
| SCHEMBL6276927 | 0.84 | ALDH1A1 (0.40) | KDM4EALDH1A1HPGDTDP1TBXA2R | |
| SCHEMBL6271682 | 0.84 | MAOA (0.48) | KDM4EALDH1A1HPGDTDP1TBXA2R | |
| SCHEMBL6272596 | 0.83 | GLA (0.50) | KDM4EALDH1A1HPGDTDP1TBXA2R | |
| SCHEMBL6276240 | 0.82 | NQO1 (0.41) | KDM4EALDH1A1HPGDTDP1PTGDR2 | |
| SCHEMBL6270511 | 0.82 | KDM4E (0.43) | KDM4EALDH1A1HPGDTDP1TBXA2R | |
| SCHEMBL6277151 | 0.81 | ALDH1A1 (0.43) | KDM4EALDH1A1HPGDTDP1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1273578-B1 | Benzopyran derivatives and antiallergic agent containing the same | DAINIPPON INK & CHEMICALS (JP) | 2005-02-23 | — | — | EP | disclosed |
| US-6670391-B2 | For inhibiting both immediate and delayed type allergic reactions; side effect reduction | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-12-30 | — | — | US | disclosed |
| US-20030096860-A1 | Benzopyran derivative and antiallergic agent | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-05-22 | — | — | US | disclosed |
| EP-1273578-A1 | Benzopyran derivatives and antiallergic agent containing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-01-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030096860-A1 | Benzopyran derivative and antiallergic agent | HRH2, HRH1, HRH4 | KDM4E 965/4885ALDH1A1 105/4885HPGD 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.